1. Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection 
Hsin-Tzu Liu, Michael B. Chancellor, Hann-Chorng Kuo 
European Urology 
Volume 56, Issue 4, Pages (October 2009)
DOI: /j.eururo
Copyright © 2008 European Association of Urology Terms and Conditions

2. Fig. 1
Urinary nerve growth factor/creatinine (NGF/Cr) levels in patients with (a) idiopathic detrusor overactivity (IDO) of different urgency severity scale (USS), and (b) neurogenic detrusor overactivity (NDO) with high voiding pressure (HVP), low voiding pressure (LVP), and with autonomic dysreflexia (AD) compared with the controls.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions

3. Fig. 2
Urinary nerve growth factor/creatinine (NGF/Cr) levels for responders and nonresponders among patients with idiopathic detrusor overactivity (IDO) and neurogenic detrusor overactivity (NDO) at baseline and 3 mo post–BoNT-A treatment. Asterisk means statistically significant. Data are expressed as mean±standard error.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions